{"id":16992,"date":"2013-08-18T00:00:00","date_gmt":"2013-08-17T22:00:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/big-pharma-un-generoso-compagno-paterno-medici-sotto-linfluenza-del-marketing\/"},"modified":"2013-08-18T00:00:00","modified_gmt":"2013-08-17T22:00:00","slug":"big-pharma-un-generoso-compagno-paterno-medici-sotto-linfluenza-del-marketing","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/big-pharma-un-generoso-compagno-paterno-medici-sotto-linfluenza-del-marketing\/","title":{"rendered":"BIG PHARMA: a generous paternal companion. DOCTORS UNDER THE INFLUENCE OF MARKETING"},"content":{"rendered":"<p><span style=\"font-size: medium;\"><span lang=\"it\" id=\"result_box\"><span class=\"hps\">The China<\/span> <span class=\"hps\">size i<\/span> <span class=\"hps\">maximum prices<\/span> <span class=\"hps\">of retail<\/span> <span class=\"hps\">more<\/span> <span class=\"hps\">400 varieties<\/span> <span class=\"hps\">of drugs<\/span> <span class=\"hps\">in<\/span> <span class=\"hps\">an average of 15<\/span> <span class=\"hps\">percent<\/span>, <span class=\"hps\">including products<\/span> <span class=\"hps\">Of<\/span> <span class=\"hps\">Pfizer<\/span> <span class=\"hps\">Inc.<\/span> <span class=\"hps atn\">(<\/span>PFE), <span class=\"hps\">Novartis<\/span> <span class=\"hps\">AG<\/span> <span class=\"hps atn\">(<\/span>NOVN) <span class=\"hps\">and Merck<\/span> <span class=\"hps\">&amp; Co.<\/span> <span class=\"hps atn\">(<\/span>MRK), <span class=\"hps\">to reduce the<\/span> <span class=\"hps\">healthcare costs<\/span> <span class=\"hps\">in the nation<\/span>.<\/span><br \/> <span lang=\"it\" id=\"result_box\"><span lang=\"it\" id=\"result_box\"><span class=\"hps\">Changes<\/span>, effective <span class=\"hps\">from February 1st<\/span>, <span class=\"hps\">they will concern<\/span> <span class=\"hps\">drugs used<\/span> <span class=\"hps\">for respiratory diseases<\/span> <span class=\"hps\">and for the pain<\/span>, <span class=\"hps\">as well as others<\/span> <span class=\"hps\">drugs<\/span> <span class=\"hps\">specialized<\/span> <span class=\"hps\">he said in<\/span> <span class=\"hps\">a statement about<\/span> <span class=\"hps\">its website<\/span> the National Development and Reform Commission.<\/span><span class=\"hps\"><br \/> This is the<\/span> <span class=\"hps\">fourth series of <\/span><span class=\"hps\">state mandates<\/span> <span class=\"hps\">for price adjustments<\/span> <span class=\"hps\">as of 2011<\/span>, <span class=\"hps\">with the previous ones<\/span> <span class=\"hps\">cuts<\/span> <span class=\"hps\">for drugs<\/span>, including antibiotics, <span class=\"hps\">vaccines and<\/span> <span class=\"hps\">anti-cancer drugs<\/span>. <span class=\"hps\">The<\/span> <span class=\"hps\">government wants<\/span> <span class=\"hps\">reduce medical expenses<\/span> <span class=\"hps\">for the<\/span> <span class=\"hps\">population<\/span> Chinese <span class=\"hps\">he reported <\/span> <span class=\"hps\"><span lang=\"it\" id=\"result_box\"> <span class=\"hps\">Shanghai Securities News<\/span><\/span> quoting<\/span> <span class=\"hps\">the Minister of Health<\/span> <span class=\"hps\">chen<\/span> <span class=\"hps\">Zhu<\/span>.<br \/> <span class=\"hps\">Among the products<\/span> <span class=\"hps\">interested<\/span> <span class=\"hps\">there are the Singular for the treatment of asthma<\/span> Of <span class=\"hps\">Merck<\/span>, the Linezolid&nbsp; <span class=\"hps\">an antibiotic<\/span> Pfizer&#039;s Trileptal, an epilepsy drug  <span class=\"hps\">by Novartis<\/span> <span class=\"hps\">second<\/span> <span class=\"hps\">a price list<\/span> <span class=\"hps\">issued by<\/span> <span class=\"hps\">government.<\/span><br \/> <span class=\"hps\">The prices of<\/span> <span class=\"hps\">drugs<\/span> <span class=\"hps\">high-end<\/span> <span class=\"hps\">will be reduced<\/span> <span class=\"hps\">on average<\/span> <span class=\"hps\">by 20 percent<\/span> second <span class=\"hps\">the last adjustment<\/span>, <span class=\"hps\">While<\/span> <span class=\"hps\">some items<\/span> <span class=\"hps\">cheap<\/span> <span class=\"hps\">who offer one<\/span> <span class=\"hps\">limited offer<\/span> <span class=\"hps\">they will have theirs<\/span> <span class=\"hps\">price<\/span> <span class=\"hps\">high<\/span> <span class=\"hps\">to encourage production<\/span>.<\/span><\/span><span lang=\"it\" id=\"result_box\"><br \/> <\/span><\/p>\n<p style=\"text-align: right;\"><span style=\"font-size: medium;\"><strong><span lang=\"it\">Translation by Riccardo Brevilacqua<\/span><\/strong><\/span><\/p>\n<p><span lang=\"it\">Source: <a","protected":false},"excerpt":{"rendered":"<p>La Cina taglia i prezzi massimi di vendita al dettaglio di oltre 400 variet&agrave; di farmaci in una media del 15 per cento, compresi i prodotti di Pfizer Inc. (PFE), Novartis AG (NOVN) e Merck &amp; Co. (MRK), per ridurre i costi sanitari nella nazione. Le modifiche, efficaci dal 1 febbraio, riguarderanno farmaci utilizzati per &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16992"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}